Aristo Bio-Tech and Lifescience (NSE:ARISTO) EBIT per Share: ₹10.97 (TTM As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹109.25
View Full Analysis

What is Aristo Bio-Tech and Lifescience EBIT per Share?

Aristo Bio-Tech and Lifescience NSE:ARISTO 59 EBIT per Share is ₹10.97 as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

Aristo Bio-Tech and Lifescience's EBIT per Share for the six months ended in Mar. 2025 was ₹0.56. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹10.97.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Aristo Bio-Tech and Lifescience's EBIT per Share or its related term are showing as below:

NSE:ARISTO's 3-Year EBIT Growth Rate is not ranked *
in the Agriculture industry.
Industry Median: -5.8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Aristo Bio-Tech and Lifescience's EBIT for the six months ended in Mar. 2025 was ₹4 Mil.

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Aristo Bio-Tech and Lifescience EBIT per Share Related Terms

Aristo Bio-Tech and Lifescience EBIT per Share Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience EBIT per Share Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBIT per Share
Get a 7-Day Free Trial 5.45 5.67 13.10 10.86 10.97

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EBIT per Share Get a 7-Day Free Trial Premium Member Only 3.78 6.76 4.10 10.42 0.56
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Aristo Bio-Tech and Lifescience's EBIT per Share for the fiscal year that ended in Mar. 2025 is calculated as

EBIT per Share(A: Mar. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=74.677/6.808
=10.97

Aristo Bio-Tech and Lifescience's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

EBIT per Share(Q: Mar. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=3.785/6.809
=0.56

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹10.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of ₹10.97 mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a EBIT per Share of ₹10.97 as of Mar. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's EBIT per Share too high?
Aristo Bio-Tech and Lifescience's current EBIT per Share is ₹10.97. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's EBIT per Share compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's EBIT per Share of ₹10.97 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Agriculture company?
A good EBIT per Share depends on the Agriculture industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current EBIT per Share is ₹10.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current EBIT per Share of ₹10.97. The current EBIT per Share is ₹10.97. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current EBIT per Share is ₹10.97 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹109.25
Price